KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Capital Expenditures (2016 - 2025)

Bausch Health Companies' Capital Expenditures history spans 17 years, with the latest figure at $92.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 13.21% year-over-year to $92.0 million; the TTM value through Dec 2025 reached $397.0 million, up 17.8%, while the annual FY2025 figure was $397.0 million, 17.8% up from the prior year.
  • Capital Expenditures for Q4 2025 was $92.0 million at Bausch Health Companies, up from $91.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $115.0 million in Q1 2025 and bottomed at $28.0 million in Q2 2023.
  • The 5-year median for Capital Expenditures is $68.5 million (2021), against an average of $71.8 million.
  • The largest annual shift saw Capital Expenditures plummeted 46.15% in 2023 before it soared 178.57% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $78.0 million in 2021, then dropped by 15.38% to $66.0 million in 2022, then surged by 48.48% to $98.0 million in 2023, then grew by 8.16% to $106.0 million in 2024, then fell by 13.21% to $92.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Capital Expenditures are $92.0 million (Q4 2025), $91.0 million (Q3 2025), and $99.0 million (Q2 2025).